Australian Market Maintains Slight Losses In Mid-market

RTTNews | 35 days ago
Australian Market Maintains Slight Losses In Mid-market

(RTTNews) - The Australian stock market is maintaining its slight losses in mid-market moves on Wednesday, snapping a five-session winning streak, with the benchmark S&P/ASX 200 staying well below the 8,300 level, following the mixed cues from Wall Street overnight, with a mixed performance across most sectors. Traders are also booking some profits following the recent upside in the markets.

The benchmark S&P/ASX 200 Index is losing 8.70 points or 0.11 percent to 8,260.30, after hitting a low of 8,247.00 earlier. The broader All Ordinaries Index is down 4.70 points or 0.06 percent to 8,506.00. Australian stocks ended modestly higher on Tuesday.

Among major miners, BHP Group is losing almost 1 percent, Rio Tinto is edging down 0.2 percent, while Mineral Resources is gaining more than 1 percent and Fortescue metals is adding almost 1 percent.

Oil stocks are mostly higher. Woodside Energy is adding more than 3 percent, Santos is edging up 0.3 percent and Beach energy is gaining almost 1 percent, while Origin Energy is losing almost 2 percent.

In the tech space, Afterpay owner Block is surging more than 6 percent, Zip is advancing almost 6 percent and Appen is adding more than 4 percent, while WiseTech Global and Xero are gaining more than 1 percent each.

Among the big four banks, National Australia bank and Commonwealth Bank are gaining almost 1 percent each, while Westpac is losing almost 1 percent and ANZ Banking is edging up 0.1 percent.

Among gold miners, Evolution Mining is gaining almost 1 percent, Gold Road Resources is up almost 2 percent and Resolute Mining is adding more than 2 percent, while Newmont is declining almost 2 percent and Northern Star Resources is losing more than 1 percent.

In other news, shares in Aristocrat Leisure are tumbling almost 13 percent after the gaming technology company reported downbeat half-year results.

Shares in Insignia Financial are plunging almost 15 percent after the Bain Capital pulled out from takeover talks amid volatility in global capital markets.

In the currency market, the Aussie dollar is trading at $0.648 on Wednesday.

read more
UK Inflation Slows Slightly In May

UK Inflation Slows Slightly In May

UK consumer price inflation softened in May as the slowdown in transportation costs was largely offset by the rise in food prices and reinforced expectations that the Bank of England will maintain the interest rate steady this week. The consumer price index registered an annual increase of 3.4 percent, slightly slower than the 3.5 percent rise seen in April, the Office for National Statistics said
RTTNews | 36 minutes ago
Bank Indonesia Holds Interest Rate Steady At 5.5% As Expected; Hints At Reduction

Bank Indonesia Holds Interest Rate Steady At 5.5% As Expected; Hints At Reduction

Indonesia's central bank left its benchmark interest rate unchanged on Wednesday after a quarter-point reduction in May and hinted at further reduction to support economic growth. The Bank Indonesia Board, led by Governor Perry Warjiyo, maintained the BI rate at 5.50 percent. The bank had reduced the rates twice this year, in May and January.
RTTNews | 1h 15min ago
CPI Softening Boosts FTSE 100

CPI Softening Boosts FTSE 100

Better-than-expected CPI readings from the U.K. bolstered sentiment, helping FTSE 100 outperform its peers.
RTTNews | 1h 28min ago
CAC 40 Retreats After Short-lived Rebound

CAC 40 Retreats After Short-lived Rebound

Despite attempting a rebound, the CAC 40 index that tracks the 40 largest French stocks based on the Euronext Paris has shed around half a percent in Wednesday's trading.
RTTNews | 2h 33min ago
FDA Launches Commissioner's National Priority Voucher Program

FDA Launches Commissioner's National Priority Voucher Program

The U.S. Food and Drug Administration announced launch of a new program to issue Commissioner's National Priority Vouchers or CNPVs, which shortens review time significantly, with a view to support national health priorities. The new CNPV program, which will begin in 2025, aims to accelerate the drug review process for companies while maintaining the FDA's rigorous standards for safety, efficacy..
RTTNews | 2h 45min ago